New migraine pill shows promise in large trial
Symptom relief
Completed
This study tested a new medicine, elismetrep, for treating moderate or severe migraine attacks. 431 adults with a history of migraine took either the drug or a placebo. The goal was to see if the drug could stop pain and other bothersome symptoms like nausea or sensitivity to lig…
Phase: PHASE2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC